NCT03840538View on ClinicalTrials.gov

Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

January 1, 2019

Conditions

Sjogren's Syndrome

Interventions

DRUG

Probiotic Product - Cap

probiotic capsule complex composed of L.acidophilus, L. bulgaricus, Streptococcus thermophilus, and Bifidobacterium bifidus

Trial Locations (1)

9112

Cairo University, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT03840538 - Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome | Biotech Hunter | Biotech Hunter